A New York-based radiology technology company has announced it has raised $130 million in a recent funding round, increasing its total capital raised to $370 million since the company was founded in 2016. The funding round includes a $40 million revolving credit facility, demonstrating continued investor confidence in the company’s growth and technological potential.
While the company’s name was not disclosed in the brief announcement, it is understood to be a vendor operating in the field of artificial intelligence (AI) for radiology, offering software solutions that assist healthcare providers in interpreting medical imaging studies more efficiently and accurately. Companies in this space typically develop AI tools used in hospitals and diagnostic centers to improve clinical workflows, reduce diagnostic errors, and accelerate patient care.
The infusion of capital is expected to be used for continued product development, expansion of commercialization efforts, and the potential scaling of operations into new markets. The inclusion of a revolving credit line allows flexibility for short-term financial needs, aiding the company’s ability to manage cash flows while pursuing long-term growth initiatives.
This latest investment underscores the growing investor interest in AI-driven healthcare solutions, especially in radiology where image-heavy clinical workloads can benefit significantly from automation and decision support technologies. The radiology AI market is projected to grow substantially over the next decade, driven by advancements in machine learning and increasing demand for diagnostic imaging worldwide.
With this latest financial boost, the vendor is expected to reinforce its position among leading innovators in radiology AI, further contributing to the digital transformation of medical imaging.
Source: https:// – Courtesy of the original publisher.
